Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and electrophilic xenobiotics are chemically reactive molecules that play dual roles as essential signaling messengers and mediators of cellular damage. ROS, including superoxide anions and hydrogen peroxide, are primarily generated as byproducts of mitochondrial respiration or by enzymes like NADPH oxidases (NOX), while electrophilic xenobiotics are electron-deficient foreign compounds that can covalently modify cellular nucleophiles such as DNA and proteins (Sies et al., 2017, Nature Reviews Molecular Cell Biology). Under physiological conditions, these species are tightly regulated by antioxidant systems; however, an imbalance leads to oxidative and electrophilic stress, which is a hallmark of chronic diseases including cancer, atherosclerosis, and Alzheimer's disease (Forman & Zhang, 2021, Nature Reviews Drug Discovery). While not traditional protein targets, they are therapeutically addressed through the use of antioxidants that scavenge reactive species or by pharmacological activators of the Nrf2 transcription factor, which upregulates detoxification enzymes (Baird & Dinkova-Kostova, 2011, Archives of Toxicology). Targeting the flux of these reactive species remains a challenge due to the risk of disrupting beneficial redox-sensitive pathways required for normal cell function and immune response.
Direct scavenging of free radicals, neutralization of electrophilic centers through nucleophilic attack, and induction of endogenous antioxidant defenses via the Keap1-Nrf2-ARE signaling pathway.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and electrophilic xenobiotics (ROS/Electrophiles).